Ledger Run acquires Assentia for enhanced services and ClinRun platform integration.

Ledger Run has acquired Assentia, a pharmaceutical services provider known for its global clinical trial contract negotiation expertise. This acquisition aims to enhance Ledger Run's services and complement its ClinRun platform, facilitating better engagement among sponsors, sites, and CROs. The merger will expand offerings and accelerate the delivery of innovative therapies and devices to patients, benefiting the pharmaceutical and biotech sectors.

October 23, 2024
3 Articles